AssayIndex
Reports by quarter

Reports submitted in 2025-Q2 · page 10

Gravimetric mass-balance reconciliation became mandatory on new records. Median purity for the quarter is 99.05 % area, n=619. Read the 2025-Q2 state-of-the-index report →

619 records16 pagesmedian on this page 98.91 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-019962RetatrutideHJHJ-2412-C6855VendorInvestigate2025-Q297.804.03—Buyer-sourced0PASS
AX-2025-019752TirzepatideHomopeptideHOMO-2502-U4118Nordanalyt2025-Q298.205.43—Buyer-sourced0PASS
AX-2025-019704BPC-157TFCTFC-2504-J2701VendorInvestigate2025-Q299.433.9798.0Laboratory-retained0PASS
AX-2025-018810ExenatideFGPFGP-2504-V8032Medutest2025-Q299.273.9797.7Buyer-sourced0PASS
AX-2025-018699TB-500QSCQSC-2504-T6759Janoshik2025-Q299.773.6889.6Buyer-sourced2MARGINAL
AX-2025-018602N-Acetyl Semax AmideQYBQYB-2501-C5179Nordanalyt2025-Q299.936.04—Laboratory-retained0PASS
AX-2025-021210TirzepatidePPGPPG-2503-R7317PeptideMeter2025-Q299.394.2498.3Buyer-sourced0PASS
AX-2025-021064TirzepatideBCHBCH-2501-D4197PeptideMeter2025-Q297.504.57—Buyer-sourced0PASS
AX-2025-020858TB-500CPCCPC-2411-X1899Nordanalyt2025-Q299.763.39100.4Buyer-sourced2MARGINAL
AX-2025-021198RetatrutidePPGPPG-2501-B7212Janoshik2025-Q299.184.11—Buyer-sourced0PASS
AX-2025-021117EpitalonSIGSIG-2505-6146Janoshik2025-Q298.668.99100.5Buyer-sourced0FAIL
AX-2025-020917SurvodutideWXTWXT-2501-X2463Nordanalyt2025-Q298.323.8398.1Supplier-supplied2MARGINAL
AX-2025-020029IpamorelinSWBSWB-2501-Y7592Janoshik2025-Q299.494.20104.1Buyer-sourced1MARGINAL
AX-2025-019948SemaglutideHJHJ-2504-Y7274Janoshik2025-Q298.645.3690.8Buyer-sourced1MARGINAL
AX-2025-020441SemaxKPKP-2502-H5248PeptideMeter2025-Q298.865.90—Laboratory-retained0PASS
AX-2025-020439SemaxKPKP-2502-H5248VendorInvestigate2025-Q298.386.81103.2Buyer-sourced0FAIL
AX-2025-020332BPC-157GGPepsGGPE-2411-V3137Janoshik2025-Q298.692.58—Buyer-sourced0PASS
AX-2025-019985TirzepatideHJHJ-2505-H6642Janoshik2025-Q298.535.43—Buyer-sourced0PASS
AX-2025-019980TirzepatideHJHJ-2505-H6642Janoshik2025-Q298.555.33—Buyer-sourced0PASS
AX-2025-019496LiraglutideJEEPJEEP-2411-B9021Janoshik2025-Q299.135.0590.5Buyer-sourced0PASS
AX-2025-019102RetatrutideGSPGSP-2411-B2857Janoshik2025-Q298.037.2298.7Buyer-sourced0PASS
AX-2025-019101RetatrutideGSPGSP-2411-B2857Medutest2025-Q298.367.25—Buyer-sourced0PASS
AX-2025-021142GHK-CuSIGSIG-2503-6560Janoshik2025-Q297.846.66—Buyer-sourced0PASS
AX-2025-020775AdipotideCPCCPC-2502-C9355Medutest2025-Q297.485.21102.9Buyer-sourced1FAIL
AX-2025-019241AOD-9604AMBAMB-2411-S5560VendorInvestigate2025-Q299.024.8696.1Buyer-sourced0PASS
AX-2025-019188TirzepatideSinoPepSNP-2411-Y4474Janoshik2025-Q298.293.81101.8Buyer-sourced0PASS
AX-2025-019112RetatrutideGSPGSP-2411-B2857Nordanalyt2025-Q298.347.6794.6Buyer-sourced0PASS
AX-2025-021208TirzepatidePPGPPG-2503-R7317Medutest2025-Q298.883.94—Buyer-sourced0PASS
AX-2025-021070HexarelinBCHBCH-2501-B4807Janoshik2025-Q298.475.5298.5Supplier-supplied0FAIL
AX-2025-0205435-Amino-1MQSSASSA-2501-N6781VendorInvestigate2025-Q299.413.07—Buyer-sourced0FAIL
AX-2025-020085TirzepatideSWBSWB-2505-R8575Nordanalyt2025-Q298.962.9497.8Buyer-sourced1MARGINAL
AX-2025-019621AdipotideTFCTFC-2411-R1539Janoshik2025-Q298.973.18106.3Buyer-sourced0PASS
AX-2025-019544CJC-1295 (no DAC)TFCTFC-2411-M9928Janoshik2025-Q299.032.53102.6Buyer-sourced0PASS
AX-2025-019050Thymosin α1ASYASY-{CAT}-2031Janoshik2025-Q298.934.36—Buyer-sourced0PASS
AX-2025-018612GHRP-6QYBQYB-2504-H5023Janoshik2025-Q299.576.23—Buyer-sourced0PASS
AX-2025-021154IpamorelinPPGPPG-2505-U7155Janoshik2025-Q299.604.3589.4Buyer-sourced1MARGINAL
AX-2025-020965TirzepatideWXTWXT-2411-F3188PeptideMeter2025-Q299.624.4793.5Supplier-supplied0PASS
AX-2025-020618MK-677 (Ibutamoren mesylate)GL BiochemGLBI-2501-Y7989PeptideMeter2025-Q298.735.01—Buyer-sourced1FAIL
AX-2025-0205425-Amino-1MQSSASSA-2501-N6781Janoshik2025-Q299.383.16103.3Buyer-sourced0FAIL
AX-2025-020422KPVMKMMKM-2504-N4868Medutest2025-Q299.935.28—Laboratory-retained0FAIL